DK1675621T3 - Farmaceutiske præparater af lavendustin - Google Patents

Farmaceutiske præparater af lavendustin

Info

Publication number
DK1675621T3
DK1675621T3 DK04764259T DK04764259T DK1675621T3 DK 1675621 T3 DK1675621 T3 DK 1675621T3 DK 04764259 T DK04764259 T DK 04764259T DK 04764259 T DK04764259 T DK 04764259T DK 1675621 T3 DK1675621 T3 DK 1675621T3
Authority
DK
Denmark
Prior art keywords
lavender
dust
pharmaceutical preparations
emollient
methoxy
Prior art date
Application number
DK04764259T
Other languages
Danish (da)
English (en)
Inventor
Katrin Kriwet
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Application granted granted Critical
Publication of DK1675621T3 publication Critical patent/DK1675621T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Toxicology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK04764259T 2003-08-19 2004-08-18 Farmaceutiske præparater af lavendustin DK1675621T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0319497.4A GB0319497D0 (en) 2003-08-19 2003-08-19 Organic compounds
PCT/EP2004/009273 WO2005016322A2 (en) 2003-08-19 2004-08-18 Pharmaceutical compositions of lavendustin

Publications (1)

Publication Number Publication Date
DK1675621T3 true DK1675621T3 (da) 2007-05-21

Family

ID=28052795

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04764259T DK1675621T3 (da) 2003-08-19 2004-08-18 Farmaceutiske præparater af lavendustin

Country Status (19)

Country Link
US (2) US20060205746A1 (ja)
EP (1) EP1675621B1 (ja)
JP (1) JP2007502799A (ja)
CN (1) CN100490899C (ja)
AT (1) ATE355084T1 (ja)
AU (1) AU2004264680B2 (ja)
BR (1) BRPI0413545A (ja)
CA (1) CA2534492A1 (ja)
CY (1) CY1106510T1 (ja)
DE (1) DE602004005064T2 (ja)
DK (1) DK1675621T3 (ja)
ES (1) ES2280045T3 (ja)
GB (1) GB0319497D0 (ja)
HK (1) HK1092699A1 (ja)
MX (1) MXPA06001886A (ja)
PL (1) PL1675621T3 (ja)
PT (1) PT1675621E (ja)
SI (1) SI1675621T1 (ja)
WO (1) WO2005016322A2 (ja)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06312919A (ja) * 1993-05-06 1994-11-08 Kao Corp 美白剤及びこれを含有する皮膚化粧料
KR100437580B1 (ko) * 1995-03-14 2004-07-16 노파르티스 아게 삼치환된페닐유도체
US6965375B1 (en) * 2001-04-27 2005-11-15 Palm, Inc. Compact integrated touch panel display for a handheld device
US7656393B2 (en) * 2005-03-04 2010-02-02 Apple Inc. Electronic device having display and surrounding touch sensitive bezel for user interface and control
US6919678B2 (en) * 2002-09-03 2005-07-19 Bloomberg Lp Bezel-less electric display

Also Published As

Publication number Publication date
AU2004264680A1 (en) 2005-02-24
CA2534492A1 (en) 2005-02-24
CN1835770A (zh) 2006-09-20
ES2280045T3 (es) 2007-09-01
HK1092699A1 (en) 2007-02-16
US20060205746A1 (en) 2006-09-14
MXPA06001886A (es) 2006-05-17
CN100490899C (zh) 2009-05-27
DE602004005064D1 (de) 2007-04-12
WO2005016322A3 (en) 2005-11-03
EP1675621B1 (en) 2007-02-28
BRPI0413545A (pt) 2006-10-17
CY1106510T1 (el) 2012-01-25
SI1675621T1 (sl) 2007-08-31
WO2005016322A2 (en) 2005-02-24
DE602004005064T2 (de) 2007-07-12
PL1675621T3 (pl) 2007-06-29
US20080242686A1 (en) 2008-10-02
PT1675621E (pt) 2007-05-31
AU2004264680B2 (en) 2007-09-27
EP1675621A2 (en) 2006-07-05
ATE355084T1 (de) 2006-03-15
GB0319497D0 (en) 2003-09-17
JP2007502799A (ja) 2007-02-15

Similar Documents

Publication Publication Date Title
DK1412384T3 (da) Stabil formulering af modificeret GLP-1
ATE522507T1 (de) Montelukast in fester phase
CY1111693T1 (el) Αντιιικοι παραγοντες
DE60140814D1 (de) N-phenyl-2-pyrimidine-amine derivatives
DK1487829T3 (da) Thiadizolylpiperazinderivater, der er nyttige til behandling eller forebyggelse af smerte
ATE556061T1 (de) Therapeutisches oder prophylaktisches mittel gegen multiple sklerose
SE0300010D0 (sv) Novel Compounds
BRPI0108395B8 (pt) derivados de pirrolopirimidinona, processos de preparação e uso
DE60317326D1 (de) Phenylalkansäure- und phenyloxyalkansäure-derivate als hppar aktivatore
DE60206911D1 (de) Imidazol-2-carbonsäureamid derivate als raf-kinase-inhibitoren
EA200870545A1 (ru) Новые гетероциклические соединения
NO20035438L (no) Farmasoytisk formulering for effektiv administrering av apomorfin, 6aR-(-)-N-propyl-norapomorfin og deres derivater og prodrugs derav
NO20072515L (no) 2-amido-4-fenyltnazolderivater, fremstilling og terapeutsik anvendelse derav
HUP0303460A2 (hu) IgE-Módosító és sejtburjánzásgátló hatású benzimidazolok és ezeket tartalmazó gyógyszerkészítmények
BRPI0415053A (pt) inibidor de p-glicoproteìna, método para preparar o mesmo e composição farmacêutica que compreende o mesmo
HRP20041056B1 (en) 6-11 bicyclic ketolide derivatives
SE0102440D0 (sv) New compound
EE200300501A (et) Ninna manustatavad imidasotriasinooni sisaldavad kompositsioonid
ATE308540T1 (de) Antithrombosemittel
DK1412332T3 (da) Quinolinderivater og anvendelse deraf som antitumormidler
DK1675621T3 (da) Farmaceutiske præparater af lavendustin
ATE497761T1 (de) Therapeutisches oder prophylaktisches mittel gegen leukämie
DE69828522D1 (de) Antithrombotische mittel
BRPI0411772A (pt) uso de derivados de biciclo[2.2.1]heptano para o preparo de composições farmacêuticas neuroprotetoras
SE0004827D0 (sv) Therapeutic compounds